Chemical Compound

Cucurbitacin E

CAS Registry Number 18444-66-1
Cucurbitacin E chemical structure
Primary Record

Cucurbitacin E

In stock
4,911 g
Purity
98.6 %
CAS
18444-66-1

Compound Identifiers & Properties

CAS
18444-66-1
PubChem CID
5281319
SMILES
CC(=O)OC(C)(C)/C=C/C(=O)[C@@](C)([C@H]1[C@@H](C[C@@]2([C@@]1(CC(=O)[C@@]3([C@H]2CC=C4[C@H]3C=C(C(=O)C4(C)C)O)C)C)C)O)O
Canonical SMILES
CC(=O)OC(C)(C)/C=C/C(=O)[C@](C)(O)[C@H]1[C@H](O)C[C@@]2(C)[C@@H]3CC=C4[C@@H](C=C(O)C(=O)C4(C)C)[C@]3(C)C(=O)C[C@]12C

Names & Synonyms

  • Cucurbitacin E
  • alpha-Elaterin
  • alpha-Elaterine
  • Cucurbitacine-E
  • 18444-66-1
  • Cucurbitacine E
  • .alpha.-Elaterin
  • Cucurbitacin-E
  • a-Elaterin
  • .alpha.-Elaterine
  • ELATERIN, ALPHA
  • -Elaterin;-Elaterine
  • AC1NQYC4
  • RefChem:128717
  • UNII-V8A45XYI21
  • V8A45XYI21
  • Cucurbitacin E (Standard)
  • CHEBI:3944
  • CUCURBITACIN E [MI]
  • (-)-CUCURBITACIN E
  • C32H44O8
  • NSC 106399
  • NSC-106399
  • SCHEMBL140616
  • MFCD00135936
  • CHEMBL455056
  • DTXSID601030496
  • orb1301289
  • Cucurbitacin E (alpha-Elaterin)
  • NSC-521775
  • EINECS 242-325-2
  • HY-N0417R
  • NDYMQXYDSVBNLL-MUYMLXPFSA-N
  • DTXCID701529571
  • HY-N0417
  • ZINC4097800
  • BRN 2343323
  • LMST01010107
  • NP7222
  • NSC106399
  • NSC521775
  • AKOS015896851
  • ACN-035422
  • C32-H44-O8
  • CID5281319
  • CS-3817
  • FC69737
  • CID:5281319
  • CUCURBITACIN E (REFERENCE GRADE)
  • AC-34285
  • AS-76174
  • DA-72424
  • J14.209C
  • SID:176223207
  • FT-0697873
  • FT-0776601
  • N2791
  • NS00094068
  • Y0059
  • 4-08-00-03731 (Beilstein Handbook Reference)
  • C08797
  • 19-Norlanosta-1,5,23-triene-3,11,22-trione,25-(acetyloxy)-2,16,20-trihydroxy-9-methyl-, (9b,10a,16a,23E)-
  • 444C661
  • A930353
  • C102326
  • [(E,6R)-6-[(8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl] acetate
  • I07-0167
  • Q5192451
  • Cucurbitacin E, 98%, from Cucumis melo L. - 5MG 5mg
  • (R,E)-6-((8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-4,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate
  • 19-Norlanosta-1,5,23-triene-3,11,22-trione, 25-(acetyloxy)-2,16,20-trihydroxy-9-methyl-, (9beta,10alpha,16alpha,23E)-
  • CUE
  • 19-Norlanosta-1,5,23-triene-3,11,22-trione, 25-(acetyloxy)-2,16,20-trihydroxy-9-methyl-, (9.beta.,10.alpha.,16.alpha.,23E)-
  • 2,16alpha,20,25-Tetrahydroxy-9beta-methyl-10alpha,-19-norlanosta-1,5,23(E)-triene-3,11,22-trione 25-acetate
  • 25-(Acetyloxy)-2,16,20-trihydroxy-9-methyl-19-norlanosta-1,5,23-triene-3,11,22-trione (9beta,10alpha,16alpha,23E)-
  • ((E,6R)-6-((8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-8,10,12,15,16,17-hexahydro-7H-cyclopenta(a)phenanthren-17-yl)-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl) acetate
  • (10alpha,23E)-25-(Acetyloxy)-2,16alpha,20-trihydroxy-9beta-methyl-19-norlanosta-1,5,23-triene-3,11,22-trione
  • (23E)-25-acetyloxy-2,16alpha,20-trihydroxy-9beta-methyl-19-nor-10alpha-lanosta-1,5,23-triene-3,11,22-trione
  • (3E,6R)-6-[(1R,2R,3aS,3bS,9aR,9bR,11aR)-2,8-dihydroxy-3a,6,6,9b,11a-pentamethyl-7,10-dioxo-1H,2H,3H,3aH,3bH,4H,6H,7H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate
  • (4R,23E)-2,16alpha,20-trihydroxy-9beta,10,14-trimethyl-1,11,22-trioxo-4,9-cyclo-9,10-secocholesta-2,5,23-trien-25-yl acetate
  • (9.BETA.,10.ALPHA.,16.ALPHA.,23E)-25-(ACETYLOXY)-2,16,20-TRIHYDROXY-9-METHYL-19-NORLANOSTA-1,5,23-TRIENE-3,11,22-TRIONE
  • (9beta,10alpha,23E)-25-(Acetyloxy)-2,16alpha,20-trihydroxy-9-methyl-19-norlanosta-1,5,23-triene-3,11,22-trione
  • (9beta,10alpha,23E)-25-Acetyloxy-2,16alpha,20-trihydroxy-9-methyl-19-norlanosta-1,5,23-triene-3,11,22-trione
  • [(E,5R)-5-[(8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthren-17-yl]-5-hydroxy-1,1-dimethyl-4-oxo-hex-2-enyl] acetate
  • 19-Nor-9-beta,10-alpha-lanosta-1,5,23-triene-3,11,22-trione, 2,16-alpha,20,25-tetrahydroxy-9-methyl-, 25-acetate
  • 19-Nor-9.beta.,10.alpha.-lanosta-1,5,23-triene-3,11,22-trione, 2,16.alpha.,20,25-tetrahydroxy-9-methyl-, 25-acetate
  • 19-Nor-9.beta.,5,23-triene-3,11,22-trione, 2,16.alpha.,20,25-tetrahydroxy-9-methyl-, 25-acetate
  • 19-Nor-9beta,10alpha-lanosta-1,5,23-triene-3,11,22-trione, 2,16alpha,20,25-tetrahydroxy-9-methyl-, 25-acetate
  • 19-Norlanosta-1,23-triene-3,11,22-trione, 25-(acetyloxy)-2,16,20-trihydroxy-9-methyl-, (9.beta.,10.alpha.,16.alpha.,23E)-
  • 2,16alpha,20,25-tetrahydroxy-9-methyl-19-nor-9beta,10alpha-lanosta-1,5,23-triene-3,11,22-trione 25-acetate
  • 242-325-2
  • Cucurbitacine E; NSC 106399; NSC 521775; |A- Elaterin; |A-Elaterine; 19-Norlanosta-1,5,23-triene-3,11,22-trione, 25-(acetyloxy)-2,16,20-trihydroxy-9-methyl-, (9B,10a,16a,23E)-; (R,E)-6-((8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-4,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate